Based on what I've read thus far the CVR doesn't sound like a great deal for OCRX shareholders. Shadowy Shares: The Dark Side of Contingent Value Rights https://www.forbes.com/sites/greatspeculations/2011/05/09/shadowy-shares-the-dark-side-of-contingent-value-rights/#4b6026733343